Monday, Apr 29 2024 | Updated at 03:40 AM EDT

Stay Connected With Us F T R

Jul 19, 2016 09:20 AM EDT

Over a century ago, a vaccine for tuberculosis was discovered. Just recently, the same vaccine is discovered to have a potential to become a vaccine for Type 1 Diabetes.

Bacillus Calmette-Guerin (BCG) has been serving as vaccine against tuberculosis for 100 years. Presently, this same vaccine is commonly used in the treatment of bladder cancer and is considered by experts to be safe.

During the 75th Scientific Sessions of the American Diabetes Association, an announcement was made saying that the Food and Drugs Administration (FDA) will test the vaccine to 150 people. These people are already in an advanced stage of type one diabetes, To Happy Life reported.

A person's body that suffers from type 1 diabetes stops producing insulin because the immune system destroys the cells that produce this substance. In turn, T cells are produced and the vaccines work by eliminating the T cells in the area.

The patients who have diabetes are injected with the vaccine. There are evidences of increased tumor necrosis factor (TNF) in the patients. The increase in TNF level will destroy the T cells that are hindering the insulin production of the body.

Patients were injected with the tuberculosis vaccine two times within a four-week time period in the previous trial. Results of the trial shows that T cells were gone, some of them already began secreting insulin without any supplements.

The new trial will have subjects with ages from 18 to 60 years old and will use the same format as before. The patients will get their injections twice in a four-week time span and then get one per year for the next four years.

There are previous study on the effectiveness of Bacillus Calmette-Guerin (BCG) against diabetes in children aged 5 to 18 years old. The results says that the vaccine does not preserve the beta-cell function or increase the remission rate in children. The results were published in the Diabetes Care journal. 

 

See Now: Covert Team Inside Newsweek Revealed as Key Players in False Human Trafficking Lawsuit

Follows Bacillus Calmette-Guerin, tumor necrosis factor, treatment
© 2024 University Herald, All rights reserved. Do not reproduce without permission.

Must Read

Common Challenges for College Students: How to Overcome Them

Oct 17, 2022 PM EDTFor most people, college is a phenomenal experience. However, while higher education offers benefits, it can also come with a number of challenges to ...

Top 5 Best Resources for Math Students

Oct 17, 2022 AM EDTMath is a subject that needs to be tackled differently than any other class, so you'll need the right tools and resources to master it. So here are 5 ...

Why Taking a DNA Test is Vital Before Starting a Family

Oct 12, 2022 PM EDTIf you're considering starting a family, this is an exciting time! There are no doubt a million things running through your head right now, from ...

By Enabling The Use Of Second-Hand Technology, Alloallo Scutter It's Growth While Being Economically And Environmentally Friendly.

Oct 11, 2022 PM EDTBrands are being forced to prioritise customer lifetime value and foster brand loyalty as return on advertising investment plummets. Several brands, ...